Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Maj 2021

Planlagt Fastgjort Låst Flyttet Genmab
1.2k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • E Offline
    E Offline
    E_L
    wrote on sidst redigeret af
    #483

    morgan stanley basically remains the same
    at 2259 (from 2248)

    1 Reply Last reply
    0
    • Helge_LarsenPI-redaktørH Offline
      Helge_LarsenPI-redaktørH Offline
      Helge_LarsenPI-redaktør
      wrote on sidst redigeret af
      #484

      Aktier/åbning: Sur start på dagen med pres på Vestas og Ambu:
      https://www.proinvestor.com/investornyt/674920/aktier-abning-sur-start-pa-dagen-med-pres-pa-vestas-og-ambu

      1 Reply Last reply
      0
      • K Offline
        K Offline
        kkjoel
        wrote on sidst redigeret af
        #485

        EL, was that an official MS upgrade of price target on Gen? And are they still "neutral weight"?

        1 Reply Last reply
        0
        • E Offline
          E Offline
          E_L
          wrote on sidst redigeret af
          #486

          Just a moment...

          favicon

          (www.streetinsider.com)

          1 Reply Last reply
          0
          • K Offline
            K Offline
            kkjoel
            wrote on sidst redigeret af
            #487

            Tnx. I see it's within their premium-wall, but the basic headline suffices....... I suppose 😉

            1 Reply Last reply
            0
            • E Offline
              E Offline
              E_L
              wrote on sidst redigeret af
              #488

              Researchers find CD38-targeting drugs may show promise against prostate cancer http://www.pharmatimes.com/news/researchers_find_cd38-targeting_drugs_may_show_promise_against_prostate_cancer_1369656

              1 Reply Last reply
              0
              • Helge_LarsenPI-redaktørH Offline
                Helge_LarsenPI-redaktørH Offline
                Helge_LarsenPI-redaktør
                wrote on sidst redigeret af
                #489

                "The study suggests that CD38-targeting therapies, including Janssen’s multiple myeloma drug Darzalex (daratumumab), may therefore offer a promising new treatment type for prostate cancer patients".

                1 Reply Last reply
                0
                • L Offline
                  L Offline
                  lahn1
                  wrote on sidst redigeret af
                  #490

                  Utroligt som DARA har potentiale. Tilbage til et gammelt saying " Put Darzalex i drikkevandet" 🙂

                  1 Reply Last reply
                  0
                  • P Offline
                    P Offline
                    peter12
                    wrote on sidst redigeret af
                    #491

                    Jeg mener MD Andersson kører et klinisk studie i prostate cancer...

                    1 Reply Last reply
                    0
                    • P Offline
                      P Offline
                      peter12
                      wrote on sidst redigeret af
                      #492

                      ClinicalTrials.gov

                      favicon

                      (clinicaltrials.gov)

                      1 Reply Last reply
                      0
                      • SolsenS Offline
                        SolsenS Offline
                        Solsen
                        wrote on sidst redigeret af
                        #493

                        Mon ikke Genmab skulle smide et forsøg med hexa38 i gang på den indikation. De har jo udtalt at hexa38 egner sig bedre til solide end dara.

                        1 Reply Last reply
                        0
                        • E Offline
                          E Offline
                          E_L
                          wrote on sidst redigeret af
                          #494

                          they are also running prostate c trials now in the UK according to this

                          • New type of treatment could reawaken immune response against prostate cancer https://www.icr.ac.uk/news-archive/new-type-of-treatment-could-reawaken-immune-response-against-prostate-cancer which follows this publication - https://www.sciencedirect.com/science/article/pii/S0302283821000221?via%3Dihub
                          1 Reply Last reply
                          0
                          • JørgenVarnæsJ Offline
                            JørgenVarnæsJ Offline
                            JørgenVarnæs
                            wrote on sidst redigeret af
                            #495

                            GEN is doing relatively well today - could we be seeing a bit of Asco build-up?

                            1 Reply Last reply
                            0
                            • JørgenVarnæsJ Offline
                              JørgenVarnæsJ Offline
                              JørgenVarnæs
                              wrote on sidst redigeret af
                              #496

                              It would be nice with signs of life from Europes second best biotech…

                              1 Reply Last reply
                              0
                              • JørgenVarnæsJ Offline
                                JørgenVarnæsJ Offline
                                JørgenVarnæs
                                wrote on sidst redigeret af
                                #497

                                The best one has decided to build af factory - https://www.wsj.com/articles/biontech-to-make-covid-19-vaccines-in-singapore-11620624600

                                1 Reply Last reply
                                0
                                • Helge_LarsenPI-redaktørH Offline
                                  Helge_LarsenPI-redaktørH Offline
                                  Helge_LarsenPI-redaktør
                                  wrote on sidst redigeret af
                                  #498

                                  Q1 webcast: Se Genmabs ledelse i Q&A med analytikere https://www.proinvestor.com/investornyt/674947/q1-webcast-se-genmabs-ledelse-i-qampa-med-analytikere

                                  1 Reply Last reply
                                  0
                                  • Helge_LarsenPI-redaktørH Offline
                                    Helge_LarsenPI-redaktørH Offline
                                    Helge_LarsenPI-redaktør
                                    wrote on sidst redigeret af
                                    #499

                                    Spørgsmål til Q&A er meget velkommen. 🙂

                                    1 Reply Last reply
                                    0
                                    • SolsenS Offline
                                      SolsenS Offline
                                      Solsen
                                      wrote on sidst redigeret af
                                      #500

                                      Lidt om Amivantamab https://www.jbc.org/article/S0021-9258(21)00427-0/fulltext

                                      1 Reply Last reply
                                      0
                                      • SolsenS Offline
                                        SolsenS Offline
                                        Solsen
                                        wrote on sidst redigeret af
                                        #501

                                        JV du rangerer biotech efter EV og ikke talent 🙂

                                        1 Reply Last reply
                                        0
                                        • JørgenVarnæsJ Offline
                                          JørgenVarnæsJ Offline
                                          JørgenVarnæs
                                          wrote on sidst redigeret af
                                          #502

                                          Jeg var ikke klar over, at der var forskel…

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger